Bio Medica Laboratories shareholders and shareholding pattern
NSE: BMLLPharmaceuticals & Biotechnology
Bio Medica Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2026 · Issue price ₹139
Last close ₹146.10down ₹8.80 (5.68%)
Share price at the NSE close on 29 Oct 2026. Previous close ₹154.90.
29 Oct: open ₹146.10, high ₹146.10, low ₹146.10
Range of traded prices from listing on 29 May 2026 to 29 Oct 2026
₹101.50Low, 3 Jun 2026₹181.00High, 4 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹184 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 15.74
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in May 2026
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 44.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 1.97
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,000100.0% delivered
Bio Medica Laboratories' shareholding pattern for Sep 2026, filed on 17 Oct 2026: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Bio Medica Laboratories, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters67.70%
- Foreign institutions4.77%
- Indian institutions3.61%
- Individuals and others23.92%
| Per cent | Sep 2026 |
|---|---|
| 67.70% | |
| Indian promoters | 67.70% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 32.30% |
| Shares in issue | 1,25,75,001 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 88,03,001 |
| Promoters' shares locked in | 85,12,909 |
A dash is a line the filing did not state.
Bio Medica Laboratories promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is MUKESH MEHTA, 33.85%.
| Holder | |||
|---|---|---|---|
| MUKESH MEHTAIndividuals and Hindu undivided families | 33.85% | 42,56,316 | 100.00% |
| PRADEEP MEHTAIndividuals and Hindu undivided families | 33.85% | 42,56,225 | 100.00% |
| GARIMA MEHTAIndividuals and Hindu undivided families | 0.00% | 92 | 100.00% |
| LOKESH JAINIndividuals and Hindu undivided families | 0.00% | 92 | 100.00% |
| ANJU MEHTAIndividuals and Hindu undivided families | 0.00% | 92 | 100.00% |
| TARA MEHTAIndividuals and Hindu undivided families | 0.00% | 92 | 100.00% |
No promoter shares are reported as pledged. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.
Largest public holders of Bio Medica Laboratories, filing by filing
Per cent, on the same shares as the split above.
| Holder | Sep 2026 |
|---|---|
| TIGER STRATEGIES FUND -IAlternative investment funds | 2.31% |
| PINE OAK GLOBAL FUNDForeign portfolio investors, category I | 2.07% |
| BASE ENGINEERING LLPCompanies | 1.59% |
| EMINENCE GLOBAL FUND PCC- EUBILIA CAPITAL PARTNERS FUND IForeign portfolio investors, category I | 1.59% |
| ALOK KUMARResident individuals, over ₹2 lakh at face value | 1.59% |
| CAPITAL TRADE LINKS LIMITEDNon-bank lenders registered with RBI | 1.30% |
| MOHAMMAD ASHRAF QURESHIResident individuals, over ₹2 lakh at face value | 1.27% |
| RATHOD MANOJ CHHAGANLAL HUFOther non-institutions | 1.07% |
| JAYANT BABULAL BOKADIAResident individuals, over ₹2 lakh at face value | 1.03% |
| DHANADEEPA CONSULTANT PRIVATE LIMITEDCompanies | 1.02% |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the May 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Foreign institutions: PINE OAK GLOBAL FUND newly named at 2.07%; EMINENCE GLOBAL FUND PCC- EUBILIA CAPITAL PARTNERS FUND I newly named at 1.59%
- Indian institutions: CAPITAL TRADE LINKS LIMITED newly named at 1.30%
- Individuals and others: YASHWANT AMRATLAL THAKKAR no longer named, from 1.72%; ALOK KUMAR newly named at 1.59%; BASE ENGINEERING LLP newly named at 1.59%; 6 more moved